NRC Health (NRC)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $558.76M
Last updated: Nov 17, 2026 at 4:15 PM ET
NRC Health (NRC) Statistics
NRC Health (NRC) has a market cap of $558.76M and an enterprise value of $658.04M. Its return on invested capital of 11.01% compares with a 1.43% median across 8 similar companies.
Total Valuation
Enterprise value is 17.77% above the market cap, as debt exceeds cash.
| Market Cap | $558.76M |
|---|---|
| Enterprise Value | $658.04M |
| Latest price (Nov 17, 2026) | $25.89 |
Key Dates
The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 29, 2026.
| Next Earnings Date | Feb 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 27, 2026 |
| Next Ex-Dividend Date | Dec 29, 2026 |
| Next Payment Date | Jan 8, 2027 |
| Fiscal Year End | December |
Valuation Ratios
The price to sales ratio is 3.9x. Its year-end P/E ranged from 16.9x to 52.3x from 2016 to 2025.
| P/E Ratio | 34.8x |
|---|---|
| P/S Ratio | 3.9x |
| Forward P/S | 3.8x |
| P/FCF Ratio | 30.5x |
| P/OCF Ratio | 23.5x |
Enterprise Valuation
Counting debt and cash, the company is valued at 27.0x EBITDA and 35.9x free cash flow.
| EV / Earnings | 102.2x |
|---|---|
| EV / Sales | 4.6x |
| EV / EBITDA | 27.0x |
| EV / EBIT | 41.4x |
| EV / FCF | 35.9x |
Price Statistics
The stock is up 74.35% over 52 weeks and trades 16.20% above its 50-day average.
| Beta (1Y) | 0.80 |
|---|---|
| 52-Week Change | +74.35% |
| 1-Month Change | +26.45% |
| 3-Month Change | +18.73% |
| 6-Month Change | +40.25% |
| 5-Year Change | -44.97% |
| 10-Year Change | +55.24% |
| Total Return (1Y) | +78.66% |
| Total Return (3Y CAGR) | -12.24% |
| Total Return (5Y CAGR) | -7.79% |
| Return vs SPY (1Y) | +53.88% |
| Max Drawdown (1Y) | -46.49% |
| Max Drawdown (3Y) | -75.07% |
| Sharpe Ratio (1Y) | 0.86 |
| Correlation with SPY (1Y) | 0.19 |
| 50-Day Average | $22.28 |
| 200-Day Average | $19.29 |
| 52-Week Range | $11.45 to $27.60 |
| RSI (14 Days) | 61.8 |
| Average Volume (20 Days) | 118.90K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.64x current liabilities.
| Current Ratio | 0.64x |
|---|---|
| Quick Ratio | 0.64x |
| Debt / EBITDA | 4.20x |
| Debt / FCF | 5.58x |
| Interest Coverage | 2.90x |
Returns and Efficiency
Return on invested capital is 11.01% over the last 12 months, against a 5-year average of 29.90%.
| Return on Assets (ROA) | 4.63% |
|---|---|
| Return on Invested Capital (ROIC) | 11.01% |
| Return on Capital Employed (ROCE) | 16.31% |
| ROE (5Y Average) | 62.69% |
| ROA (5Y Average) | 20.15% |
| ROIC (5Y Average) | 29.90% |
| Asset Turnover | 1.05x |
| Receivables Turnover | 11.66x |
Taxes
Income tax took 38.74% of pretax income over the last 12 months.
| Income Tax (TTM) | $4.07M |
|---|---|
| Effective Tax Rate | 38.74% |
Scores
NRC has an Altman Z-Score of 3.32, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.32 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $143.79M over the last 12 months is up 3.37% from the 12 months before.
| Revenue | $143.79M |
|---|---|
| Revenue Growth (YoY) | +3.37% |
| Gross Profit | $143.79M |
| Operating Income | $15.91M |
| Pretax Income | $10.51M |
| Net Income | $6.44M |
| EBITDA | $24.49M |
| EBIT | $15.88M |
| Reported EPS (TTM) | $0.74 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $3.63M |
|---|---|
| Total Debt | $102.90M |
| Net Debt | $99.27M |
| Net Debt Per Share | $4.57 |
| Working Capital | -$15.13M |
| Shareholder Equity | -$9.12M |
| Tangible Book Value | -$77.31M |
| Total Assets | $139.21M |
| Total Liabilities | $148.34M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $5.32M of capital spending, operating cash flow left $18.45M of free cash flow.
| Operating Cash Flow | $23.77M |
|---|---|
| Capital Expenditures | $5.32M |
| Free Cash Flow | $18.45M |
| FCF Per Share | $0.87 |
| Depreciation and Amortization | $8.61M |
| Dividends Paid | $13.47M |
| Share Repurchases | $25.56M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 11.06%, against a 5-year average of 26.54%.
| Gross Margin | 100.00% |
|---|---|
| Operating Margin | 11.06% |
| Pretax Margin | 7.31% |
| Net Margin | 4.48% |
| EBITDA Margin | 17.03% |
| EBIT Margin | 11.04% |
| FCF Margin | 12.83% |
| Operating Margin (5Y Average) | 26.54% |
| Net Margin (5Y Average) | 18.58% |
Growth
Revenue fell 3.22% a year over 3 years, and EPS 26.47% a year.
| Revenue Growth (3Y CAGR) | -3.22% |
|---|---|
| Revenue Growth (5Y CAGR) | +0.61% |
| EPS Growth (3Y CAGR) | -26.47% |
| EPS Growth (5Y CAGR) | -19.03% |
| FCF Growth (3Y CAGR) | -15.86% |
| FCF Growth (5Y CAGR) | -15.55% |
| Operating Income Growth (3Y CAGR) | -21.41% |
| Book Value Per Share Growth (2Y CAGR) | -43.28% |
Dividends and Yields
NRC pays out 58.50% of earnings as dividends.
| Dividend Per Share (Annual) | $0.64 |
|---|---|
| Dividend Yield | 2.47% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | -14.77% |
| Dividend Growth (5Y CAGR) | +19.88% |
| Payout Ratio | 58.50% |
| FCF Payout Ratio | 73.03% |
| Earnings Yield | 2.87% |
| FCF Yield | 3.28% |
| Buyback Yield | 4.55% |
| Shareholder Yield | 6.94% |
Peer Position
Against 7 similar companies, NRC has the 4th highest P/E.
P/E RatioPeer median 16.9x
P/S RatioPeer median 2.5x
ROICPeer median 1.43%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +11.38%
Dividend YieldPeer median 0.00%
| P/E Ratio | 34.8x vs 16.9x median |
|---|---|
| P/S Ratio | 3.9x vs 2.5x median |
| ROIC | 11.01% vs 1.43% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +3.37% vs +11.38% median |
| Dividend Yield | 2.47% vs 0.00% median |
Analyst Forecast
Consensus estimates put revenue growth at 6.22% and EPS growth at 44.91% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +6.22% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +44.91% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NRC
What is NRC's market cap?
NRC Health has a market cap of $558.76M. Its enterprise value, which adds debt and subtracts cash, is $658.04M.
What is NRC's P/E ratio?
NRC Health has a trailing P/E ratio of 34.8x.
How many shares of NRC are outstanding?
NRC Health has 21.72M shares outstanding. The count is down 1.83% from a year earlier.
Does NRC pay a dividend?
Yes. NRC Health pays $0.64 a share a year, a dividend yield of 2.47%.
How much debt does NRC have?
NRC Health has $102.90M of total debt and $3.63M of cash and equivalents, a net debt position of $99.27M.
NRC pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors